Z. Karimi-Jaberi, M. Azadi
7.12 (s, 1H, NH), 7.34 (d, J = 8.4 Hz, 2H, ArH), 7.54 (d, J = 8.4 Hz, 2H, ArH),
7.44–7.60 (m, 4H, ArH) ppm;
7,7-Dimethyl-2-(4-nitrophenyl)-4-(4-chlorophenyl)-1,4,5,6,7,8-hexahydroquino-
line-5-one (4h): IR (KBr, cm-1): 3,226, 3,076, 2,964, 1,664, 1,584, 1,534, 1,496,
1,348, 828; 1H NMR (500 MHz, DMSO-d6) d: 0.82 (s, 3H, CH3), 1.00 (s, 3H, CH3),
2.18–2.29 (m, 4H, 2 9 CH2), 5.64 (d, J = 6.5 Hz, 1H), 5.81 (d, J = 6.5 Hz, 1H),
6.20 (s, 1H, NH), 7.48 (d, J = 8.0 Hz, 2H, ArH), 7.60 (d, J = 8.0 Hz, 2H, ArH),
7.38–7.46 (m, 4H, ArH) ppm;
7,7-Dimethyl-2-(4-chlorophenyl)-4-(4-methylphenyl)-1,4,5,6,7,8-hexahydroquin-
oline-5-one (4i): IR (KBr, cm-1): 3,318, 3,040, 2,956, 2,878, 1,666, 1,584, 1,496,
1
816, 774; H NMR (500 MHz, DMSO-d6) d: 0.96 (s, 3H, CH3), 1.08 (s, 3H, CH3),
2.27–2.39 (m, 4H, 2 9 CH2), 2.22 (s, 3H, CH3), 6.37 (d, J = 7.0 Hz, 1H), 6.98 (d,
J = 7.0 Hz, 1H), 7.21 (s, 1H, NH), 7.42 (d, J = 8.0 Hz, 2H, ArH), 7.78 (d,
J = 8.0 Hz, 2H, ArH), 7.57–7.71 (m, 4H, ArH) ppm;
7,7-Dimethyl-2-(4-nitrophenyl)-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-5-one
(4j): IR (KBr, cm-1): 3,278, 3,076, 2,972, 2,888, 1,655, 1,590, 1,556, 1,494, 1,398,
1,344, 843, 759, 695; 1H NMR (500 MHz, DMSO-d6) d: 0.96 (s, 3H, CH3), 1.08 (s,
3H, CH3), 2.22–2.36 (m, 4H, 2 9 CH2), 5.73 (d, J = 6.8 Hz, 1H), 6.69 (d,
J = 6.8 Hz, 1H), 6.79 (s, 1H, NH), 7.42 (d, J = 8.4 Hz, 2H, ArH), 7.78 (d,
J = 8.4 Hz, 2H, ArH), 7.28–7.36 (m, 5H, ArH) ppm;
7,7-Dimethyl-2-(4-chlorophenyl)-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-5-one
1
(4k): IR (KBr, cm-1): 3,244, 3,028, 2,984, 1,628, 1,588, 1,500, 834, 766, 696; H
NMR (500 MHz, DMSO-d6) d: 0.98 (s, 3H, CH3), 1.09 (s, 3H, CH3), 2.31–2.44 (m,
4H, 2 9 CH2), 5.70 (d, J = 6.6 Hz, 1H), 6.64 (d, J = 6.6 Hz, 1H), 6.89 (s, 1H,
NH), 7.38 (d, J = 8.4 Hz, 2H, ArH), 7.66 (d, J = 8.4 Hz, 2H, ArH), 7.52–7.66 (m,
5H, ArH) ppm;
7,7-Dimethyl-2-(4-bromophenyl)-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-5-one
(4l): IR (KBr, cm-1): 3,242, 3,038, 2,974, 1,666, 1,602, 1,506, 1,496, 832, 778, 692;
1H NMR (500 MHz, DMSO-d6) d: 0.92 (s, 3H, CH3), 1.04 (s, 3H, CH3), 2.24–2.32
(m, 4H, 2 9 CH2), 6.76 (d, J = 6.4 Hz, 1H), 7.10 (d, J = 6.4 Hz, 1H), 7.29 (s, 1H,
NH), 7.44 (d, J = 8.4 Hz, 2H, ArH), 7.70 (d, J = 8.4 Hz, 2H, ArH), 7.48–7.62 (m,
5H, ArH) ppm;
7,7-Dimethyl-2-(4-methylphenyl)-4-phenyl-1,4,5,6,7,8-hexahydroquinoline-5-
one (4m): IR (KBr, cm-1): 3,248, 3,030, 2,996, 2,980, 1,640, 1,624, 1,592, 1,490,
1
8,31, 770, 696; H NMR (500 MHz, DMSO-d6) d: 0.92 (s, 3H, CH3), 1.02 (s, 3H,
CH3), 2.27–2.31 (m, 4H, 2 9 CH2), 2.26 (s, 3H, CH3), 5.42 (d, J = 6.4 Hz, 1H),
6.23 (d, J = 6.4 Hz, 1H), 6.65 (s, 1H, NH), 7.32 (d, J = 8.4 Hz, 2H, ArH), 7.58 (d,
J = 8.4 Hz, 2H, ArH), 7.44–7.56 (m, 5H, ArH) ppm;
Results and discussion
First, 1,3-diaryl-2-propen-1-ones (chalcones) have been synthesized through the
cross-aldol condensation of arylaldehydes and acetophenones according to a
modified reported method (Scheme 1) [25].
123